Related Experiment Videos
Beta2-microglobulin in hypertensive pregnancies
P J Saudan1, T J Farrell, M A Brown
1Department of Renal Medicine, St George Hospital, University of New South Wales, Kogarah, Australia.
Abstract:
Beta2-Microglobulin (beta2-m) is a polypeptide that is freely filtered and then mostly reabsorbed and degraded in the proximal renal tubule. Beta2-m is a marker of glomerular filtration (GFR) in renal failure, whereas urinary beta2-m is a marker of proximal renal tubular dysfunction. Preeclampsia (PE) (ie, de novo hypertension in pregnancy with accompanying renal, cerebral, or liver disease or thrombocytopenia) often has renal involvement characterized by proteinuria, decreasing glomerular filtration, or renal tubular dysfunction. The aim of this study was to determine whether serum beta2-m concentration or urinary beta2-m excretion were greater in women with PE than in women with gestational hypertension (GH) (ie, isolated de novo hypertension in the second half of pregnancy) and normal pregnant women. Seventy-five pregnant women (35 with PE, 22 with GH, and 18 normotensives) were studied prospectively. Serum creatinine and beta2-m concentrations, 24-hour proteinuria, and fractional excretion (FE) of beta2-m were measured. Preeclamptics had similar serum creatinine but higher serum beta2-m (3.26+/-0.99 mg/L) than gestational hypertensives (2.44+/-0.77 mg/L; P = 0.016), and both groups had higher serum beta2-m than controls (1.62+/-0.54 mg/L; P = 0.001). FE of beta2-m was similar amongst groups (PE: 0.27%; interquartile range [IQR]: 0.20-0.86; GH: 0.21%; IQR: 0.11-0.40; controls: 0.26%, IQR: 0.12-0.69). PE is characterized by higher serum beta2-m but similar serum creatinine to GH. Because FE beta2-m is similar in these groups, this implies reduced filtering of beta2-m in PE rather than altered tubular handling of beta2-m. Further studies are now necessary to assess whether measurement of serum beta2-m is helpful in the clinical management of the hypertensive disorders of pregnancy.
Insights
Preeclampsia (PE) is linked to higher serum beta2-microglobulin (beta2-m) levels compared to gestational hypertension (GH) and normal pregnancies. This suggests reduced beta2-m filtering in PE, not altered kidney tubule function.
Area of Science:
- Nephrology
- Obstetrics
- Biochemistry
Background:
- Beta2-microglobulin (beta2-m) is filtered by glomeruli and reabsorbed by renal tubules.
- Urinary beta2-m indicates proximal tubular dysfunction, while serum beta2-m can reflect glomerular filtration rate.
- Preeclampsia (PE) often involves renal dysfunction, including impaired glomerular filtration and tubular issues.
Purpose of the Study:
- To compare serum beta2-m concentration and urinary beta2-m excretion in women with PE, gestational hypertension (GH), and normal pregnancies.
- To investigate potential differences in renal handling of beta2-m among these groups.
Main Methods:
- Prospective study of 75 pregnant women: 35 with PE, 22 with GH, and 18 normotensives.
- Measurements included serum creatinine, serum beta2-m, 24-hour proteinuria, and fractional excretion (FE) of beta2-m.
Main Results:
- Women with PE had significantly higher serum beta2-m than those with GH and controls.
- Serum creatinine levels were similar between PE and GH groups.
- Fractional excretion of beta2-m was comparable across all three groups (PE, GH, and controls).
Conclusions:
- Preeclampsia is associated with elevated serum beta2-m, independent of serum creatinine levels.
- Similar fractional excretion of beta2-m suggests reduced glomerular filtration in PE, rather than altered tubular reabsorption or degradation.
- Further research is needed to determine the clinical utility of serum beta2-m in managing hypertensive disorders of pregnancy.